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Abstract
Background: Hyperoxia is common early in the course of resuscitation of critically ill patients. It has been associated
with mortality in some, but not all, studies of cardiac arrest patients and other critically ill cohorts. Reasons for the
inconsistency are unclear and may depend on unmeasured patient confounders, the timing and duration of hyperoxia,
population characteristics, or the way that hyperoxia is defined and measured. We sought to determine whether, in a
prospectively collected cohort of mechanically ventilated patients with traumatic injuries with and without head
trauma, higher maximum partial pressure of arterial oxygen (PaO2) within 24 hours of admission would be associated
with increased risk of in-hospital mortality.
Methods: Critically ill patients with traumatic injuries undergoing invasive mechanical ventilation enrolled in the
Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study were included in this study. All arterial blood gases
(ABGs) from the first 24 hours of admission were recorded. Primary analysis was comparison of the highest PaO2
between hospital survivors and non-survivors.
Results: A total of 653 patients were evaluated for inclusion. Of these, 182 were not mechanically ventilated or did not
have an ABG measured in the first 24 hours, leaving 471 patients in the primary analysis. In survivors, the maximum
PaO2 was 141 mmHg (median, interquartile range 103 - 212) compared to 148 mmHg (IQR 105 - 209) in non-survivors
(p = 0.82). In the subgroup with head trauma (n = 266), the maximum PaO2 was 133 mmHg (IQR 97 - 187) among
survivors and 152 mmHg (108 - 229) among nonsurvivors (p = 0.19). After controlling for age, injury severity score,
number of arterial blood gases, and fraction of inspired oxygen, maximum PaO2 was not associated with increased
mortality (OR 1.27 for every fold increase of PaO2 (95% CI 0.72 - 2.25).
Conclusions: In mechanically ventilated patients with severe traumatic injuries, hyperoxia in the first 24 hours of
admission was not associated with increased risk of death or worsened neurological outcomes in a setting without
brain tissue oxygenation monitoring.
Background
Trauma accounts for approximately 10% of deaths
worldwide and causes a disproportionately high amount
of disability and lost years of life [1]. The magnitude of
this problem may be even greater than recognized, as a
significant number of patients survive hospitalization
but ultimately succumb to complications of their injuries
[2]. Therefore, improvements in management of patients
with severe traumatic injury are needed.
Exposure to supraphysiologic levels of partial pressure
of arterial oxygen (hereafter “hyperoxia”) is common in
mechanically ventilated, critically ill patients [3–9]. The ef-
fect of hyperoxia on outcomes in a non-cardiac arrest
population of critically ill patients remains unknown.
Patients with severe traumatic injury may be especially
susceptible to detrimental neurological effects of hyper-
oxia due to the prevalence of traumatic brain injury (TBI)
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in this population, but the biological and clinical effects
of hyperoxia are complex and incompletely understood
[3–5, 10–12]. The observed prevalence and degree of
hyperoxia vary widely among centers [3–9] and have been
associated with both better [13, 14] and worse [3, 6–9]
outcomes in critically ill adults.
The association of hyperoxia with outcome has been pre-
viously studied in patients with critical traumatic injury.
One large retrospective cohort analysis of TBI patients
showed a U-shaped relationship between in-hospital and
6 month mortality and arterial oxygen tension in the first
48 h of admission, but there was no significant relationship
between hyperoxia and mortality on multivariate analysis
[15]. In this study, analysis was limited to arterial blood
gases recorded according to APACHE II methodology (i.e.,
the highest alveolar-arterial gradient for patients on FiO2
0.5 or greater, or the lowest PaO2 for patients on FiO2 <
0.5). This approach would tend to select for the blood gas
associated with lowest oxygen tension and thus may not be
ideal for measurement of any potential effects of early
hyperoxia on outcomes. In another analysis focusing on
PaO2 in the first 24 h, there was an independent association
between mortality and hyperoxia (defined as PaO2 >
300 mmHg) in a TBI cohort [9]. Thus, data is mixed on this
question perhaps due to differences in the time point ana-
lyzed and approach to assessing arterial oxygen tension.
Because the peri-contusional brain tissue in TBI is at risk
for hypoxic-ischemic injury, strategies have been developed
to directly measure the partial pressure of oxygen in brain
tissue (PBrO2) using brain probe monitors to guide oxygen
management via adjustments in FiO2 and/or mean airway
pressure. A small phase II RCT suggests improved out-
comes with such an approach [16] and results of a larger
RCT studying an aggressive PBrO2-guided oxygen manage-
ment are expected soon [17]. However, these techniques
are not yet universally adopted and may not be possible in
resource-limited settings. Furthermore, even at institutions
using this modality, there is an early period of resuscitation
that occurs prior to implantation of PBrO2 monitors.
Consequently, the safe range of PaO2 in critically ill adults
without brain tissue oxygenation monitoring early after
traumatic injury is unclear.
We performed a retrospective cohort study in mech-
anically ventilated patients with severe traumatic injuries
to test the hypothesis that the maximum measured par-
tial pressure of arterial oxygen (PaO2) within 24 h of ad-
mission would be associated with an increased risk of
in-hospital mortality and that this association would be
stronger in patients with head injury.
Methods
Patients
The study population consisted of 653 consecutive patients
who were prospectively enrolled in the Validating Acute
Lung Injury Markers for Diagnosis (VALID) study on the
morning after admission to the Trauma ICU. Methods for
the VALID study have been previously published [18–20],
and the Vanderbilt Institutional Review Board approved the
study. The VALID study included critically ill patients who
were ≥18 years old and who were admitted to Vanderbilt
ICUs for at least 2 days. Of the 653 patients, 182 were
excluded from the analysis as they were not receiving
invasive mechanical ventilation or did not have a con-
firmed arterial blood gas (ABG) measured in the first
24 h of admission (Fig. 1).
Measurements
All arterial blood gas analysis measurements obtained
through arteriopuncture or arterial catheters for clinical
purposes during the first 24 h of admission were recorded.
The maximum PaO2 in the 24 h after admission, the corre-
sponding fraction of inspired oxygen (FiO2), and the num-
ber of ABGs measured during the 24 h after admission
were also recorded. Other data collection included the
APACHE II score [21], the injury severity score (ISS) [22]
and the presence or absence of head injury (i.e., any trau-
matic insult to the face, neck, cranium, or intracranial con-
tents). Head injury was noted to be present or absent based
on the report or electronic medical record documentation
of the bedside attending physician. The Glasgow Coma
Scale (GCS) score [23] at time of hospital discharge was
also included for analysis, as this has been shown to act as
a reasonable surrogate for long-term neurologic outcomes
in patients with traumatic brain injury [24].
Statistical analysis
Patients’ baseline characteristics were summarized by
median with interquartile range for continuous variables
and frequencies with percentages for categorical variables.
To compare patient’s characteristics between in-hospital
mortality groups (survivors vs. non-survivors), Wilcoxon
rank-sum test (continuous variables) and Pearson χ2 test
Fig. 1 CONSORT Diagram. Of 653 patients admitted to the Trauma
ICU during the enrollment period and assessed for eligibility, 471
had an ABG in the first 24 h from admission and were mechanically
ventilated; these patients were included in the analysis
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(categorical variables) were used. In the primary analysis,
association between the highest PaO2 measured in the 24 h
after admission and in-hospital mortality was evaluated
using a logistic regression model controlling for age, injury
severity score, number of measured ABGs, and fraction of
inspired oxygen. The ISS and age were included in the
model because they are known to have associations with
outcome in this population. The number of measured
ABGs was included because the timing and number of
ABG assessments was not standardized in this study and is
an inherent confounder of the likelihood of having a high
PaO2 measurement. As clinicians may be more likely to
check an ABG (and therefore more likely to document
hyperoxia) in patients who are receiving a high FiO2, this
was also adjusted for in the analysis. GCS was not included
in the adjustment model because this measure is heavily
affected by both sedation practices and TBI and thus may
not be internally consistent in its interaction with outcomes
of interest in this population. As a secondary investigation,
the association between the highest PaO2 and the Glasgow
Coma Scale (GCS) at time of discharge was evaluated using
a proportional odds model adjusting for the same set of
factors as in the primary analysis. A planned subgroup
analysis of those with head injury was also conducted
and reported.
In all models, the maximum PaO2 values were trans-
formed using logarithmic function. Missing baseline values
were imputed using a multiple imputation method (30-
iteration) [25]. Statistical analysis was conducted with R
version 3 (R Core Team) [26]; a two-sided significance
level of 0.05 was used for statistical inference.
Results
Clinical characteristics
The patient population consisted exclusively of critically
ill patients with severe traumatic injuries admitted to the
Vanderbilt Trauma ICU consecutively from February
2006 to February 2011 (Table 1). summarizes characteristics
of survivors and non-survivors. Survivors were significantly
younger, had higher Glasgow Coma Scale (GCS) scores and
lower APACHE II scores on admission. Gender, ISS,
number of ABGs measured, FiO2, and maximum PaO2
were not significantly different between the two groups.
In-hospital mortality and maximum PaO2
Among the 471 patients in the primary analysis, 49
(10.4%) died during hospitalization. There was no
difference between the maximum PaO2 of survivors
[median 141 mmHg (IQR 103–212)] and nonsurvivors
[148 (105–209), p = 0.82] (Fig. 2). A logistic regression
model adjusting for potential confounders showed no
association of maximum PaO2 with mortality, with an
adjusted odds ratio for every fold increase of PaO2 of 1.27
(95% CI 0.72–2.25) (Table 2).
Head injury subgroup
As the effect of hyperoxia might differ between patients
with head injury and those without, we conducted a sub-
group analysis to determine if the adjusted association
between mortality and maximum PaO2 was different for
those with head injury. Of the entire cohort of 471
patients analyzed for this study, 266 (56.5%) carried a
diagnosis of head injury. In this subgroup, the maximum
PaO2 among survivors was 133 mmHg (97–187) com-
pared to 152 mmHg (108–229) among nonsurvivors
(p = 0.19). After controlling for age, ISS, number of
ABGs measured, and the FiO2 at the time of PaO2mea-
surement, there was no significant association between
maximum PaO2 and mortality in patients with or without
head trauma (OR 1.55, 95% CI 0.79–3.02, p = 0.20, and OR
1.01, 95% CI 0.31–3.28 p = 0.98, respectively) (Table 3).
Head injury did not modify the effect of PaO2 on mortality
(p = 0.21).
To study the potential association between PaO2 and
neurologic outcomes, Glasgow Coma Scale (GCS) scores
were collected on the day of hospital discharge for all
patients. After adjusting for potential confounders, there
was no association between the maximum PaO2 mea-
sured within 24 h of admission and the GCS measured
on the day of hospital discharge (OR for maximum
PaO2 0.96, 95% CI 0.71–1.31, p = 0.82). When this ana-
lysis was restricted to patients with and without head
injury, there was still no association between maximum
PaO2 and lower GCS at discharge (OR 1.10, 95% CI
0.76–1.60 p = 0.62 in the head injury group and OR
0.66, 95% CI 0.38–1.15 p = 0.14 in the non head injury
group [Additional file 1: Tables S1, Additional file 2:
Tables S2 and Additional file 3: Tables S3]. The pres-
ence of head injury did not modify the effect of PaO2
on GCS at hospital discharge (p = 0.11) (Table 4).
APACHE II score was not included in the reported
logistic regression models because PaO2 is a component
of APACHE II. However, since APACHE II score was
associated with mortality on univariate analysis, a sensi-
tivity analysis that included APACHE II as a variable was
done for all models. Inclusion of APACHE II did not
alter the reported conclusions; these analyses are reported
in [Additional file 4: Table S4, Additional file 5: Table S5,
Additional file 6: Table S6].
Discussion
Contrary to our hypothesis, we did not find an associ-
ation between increased PaO2 within 24 h of ICU admis-
sion and in-hospital mortality in mechanically ventilated
patients with severe traumatic injuries. Additionally, we
did not detect such an association in the subgroup of
patients with head injury. These findings provide reassuring
evidence that hyperoxia early in the course of severe
traumatic injury does not have major adverse effects.
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It is worth noting that arterial hyperoxia as measured in
this study is distinct from cerebral hyperoxia (i.e., elevated
oxygen tension in brain tissue). PBrO2 monitoring in
individuals with TBI allows for an individualized approach
to oxygen targets in TBI patients [27–29] and its use may
obviate concern for brain tissue oxygen toxicity in this
population. However, this technology is not available at all
centers. Furthermore, in the early period preceding inser-
tion of the PBrO2 monitor, the management of oxygen-
ation is still empiric. It is tempting to assume that a liberal
oxygen target is best in these patients because of the high
incidence of cerebral hypo-oxygenation, as is recom-
mended in pre-hospital trauma care guidelines [29]. How-
ever, there may be some patients who would not benefit
or would be harmed by such an approach; therefore, this
question required further study. Our analysis affirms a
prior report that such an approach is indeed safe [15].
However, because the literature is mixed as to the effects
of hyperoxia in TBI and our study was not powered to
exclude a small effect in this secondary subgroup analysis,
further investigation remains warranted.
The significance of these findings is most apparent when
considered in light of the available literature on this topic.
Considerable evidence has accrued that hyperoxia can have
harmful biochemical and physiological effects. Elevated
PaO2 may increase the formation of reactive oxygen species
(ROS) in the neuronal tissue bed, favoring the induction of
neuronal cell death, and potentially contributing to poor
neurological outcomes [10, 11]. Supraphysiologic levels of
PaO2 can also cause cerebral vasoconstriction and hetero-
geneous tissue bed perfusion patterns, potentially resulting
in paradoxically lower delivery of oxygen and other import-
ant substrates to cerebral tissue [11, 30, 31].
Conversely, a beneficial effect of increased PaO2 has
been postulated for certain patient groups [14, 32]. Human
studies have associated hyperoxia with improvements in
intracranial pressure, tissue bed oxygenation in both
peri-contusional and remote neuronal tissue, and more
aerobic neural metabolic profiles in patients with TBI
[14]. Early reductions in neurologic deficits and radio-
graphic patterns of injury in patients with stroke who
were exposed to hyperoxia have also been reported, sup-
porting a potentially neuroprotective role for hyperoxia in
the injured brain [32].
In previous cohort studies, hyperoxia has been associated
with increased mortality in a variety of clinical settings
[3, 5–9, 33] but these associations have not been seen
in all studies [4, 15, 34–37]. Data in the general mechanic-
ally ventilated population have been mixed with the largest
retrospective cohort study to date finding no effect [4, 5]. A
recent meta-analysis found arterial hyperoxia to correlate







Age (Increment of 5 years) 1.20 1.10–1.31 <0.001
Injury Severity Score (Increment of 5) 1.41 1.03–1.94 0.03
Number of ABGs Measured 1.05 0.91–1.22 0.49
FiO2 at time of ABG (Increment of 10%) 0.94 0.77–1.15 0.54
Maximum PaO2 (Increment of 1 fold) 1.27 0.72–2.25 0.41
Fig. 2 No association was seen between maximum PaO2 in the first
24 h after admission and in hospital mortality in an unadjusted analysis
Table 1 Baseline characteristics of 471 critically-Ill trauma patients included in the analysis
Characteristic N Overall Survivors Non-survivors p-value
n = 471 n = 422 (89.6%) n = 49 (10.4%)
Age (Years) 471 42 (27, 55) 41 (27, 54) 51 (43, 67) <0.001
Men (n, %) 471 342 (73%) 308 (73%) 34 (69%) 0.59
Head Trauma (Yes) 471 266 (56%) 231 (55%) 35 (71%) 0.03
APACHE II score 471 25 (20, 28) 24 (20, 28) 28 (25, 31) <0.001
Injury Severity Score 470 29 (18, 36) 29 (18, 36) 29 (20, 39) 0.37
Number of ABGs measured 471 3 (2, 5) 3 (2, 5) 3 (2, 6) 0.44
FiO2 Associated with Maximum PaO2 352 0.40 (0.40, 0.60) 0.40 (0.40, 0.60) 0.40 (0.40, 0.60) 0.56
Maximum PaO2 (mmHg) 471 142 (103, 212) 141 (103, 212) 148 (105, 209) 0.82
GCS 471 11 (8, 15) 11 (9, 15) 3 (3, 9) <0.001
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with mortality but noted substantial heterogeneity of effect
that could be due to differences in study design [38].
In light of this heterogeneity, several aspects of the
current study enhance the validity of its findings. One
strength of this analysis is that all ABGs obtained in
the first 24 h after admission were analyzed rather
than just those that contributed to APACHE scoring.
Furthermore, PaO2 was analyzed as a continuous variable
with the odds ratio of mortality for every fold increase of
PaO2 above 50 mmHg reported. This measurement of
oxygen exposure differs from that used in other studies,
and may address some of the limitations of prior reports.
Past studies of hyperoxia have used an arbitrary PaO2 cut-
off of 200 or 300 mmHg, quintiles of hyperoxia exposure,
or in the minority, PaO2 as a continuous variable [3–7, 9].
We chose to analyze PaO2 as a continuous variable
because hyperoxia has no consensus definition, arbitrary
partial pressure cut-off values may not accurately reflect
biology, and because it increases statistical power. Analysis
of the data using an arbitrary cutoff that has been used in
some prior studies (300 mmHg) did not change our
results (data not shown). The highest PaO2 during the
first 24 h was chosen as a marker of exposure to
hyperoxia for this trial. This early time point was chosen
because hyperoxia is more common in our center during
the early period. Also, vulnerable tissues may be most sus-
ceptible to any ill effects of hyperoxia early after trauma.
Other publications have examined a varied range of time
points and, in some cases, only analyzed the ABG with
the lowest alveolar-arterial gradient, lowest PaO2, or aver-
age PaO2, thus potentially missing many cases of
hyperoxia exposure [8, 15]. This early time point also in-
creases the relevance of our results to the empiric man-
agement of oxygen prior to brain tissue monitor
placement in centers with PbrO2 monitoring capability.
Our study is subject to some limitations. The retrospective
design limits interpretation of the results. Although about
half of our patients were classified as having head injury, this
diagnosis was defined as the bedside physician noting head
injury in the medical record and likely includes patients with
varying degrees of trauma to the neck, face, and cranium.
Sufficient data were not collected as part of the VALID study
to know whether patients had true TBI. Other explanations
for not finding a significant difference in PaO2 between
survivors and non-survivors include a relatively low
median PaO2 observed (142 mmHg) in our entire cohort
compared with past studies of oxygen exposure (major
studies ranging from 99 to 247 mmHg) [3–9]. Add-
itionally, it is not known if risk accumulates over time
with continuing exposure to hyperoxia, and our study
was not designed to assess for such an effect. Further-
more, our study may have been underpowered to detect
a small effect of hyperoxia. With our sample size of
471, we would have had 80% power to detect an associ-
ation if the odds ratio corresponding to one-standard-
deviation increase in maximum PaO2 were 1.53. To
achieve 80% power to detect our observed OR of 1.27
would require N = 1973. Finally, there may be outcomes
associated with increased PaO2 other than mortality
that the current study did not analyze, including neuro-
logic outcomes, which have previously been shown to
worsen in association with exposure to hyperoxia [6].
However, GCS at time of discharge has been shown to
be a reasonable surrogate for longer-term neurologic
outcomes [24] and a lower GCS did not associate with
maximum PaO2 in our cohort.
Conclusions
The optimal oxygenation strategy in critically ill patients
with traumatic injuries who do not have brain tissue
monitoring remains unknown. This study finds no associ-
ation of hyperoxia with mortality or lower GCS at discharge
in a population of mechanically ventilated patients who are
critically ill with traumatic injuries. Our findings are re-
assuring that liberal oxygen supplementation can be
safely applied in the management of the general trauma
ICU population as well as in patients with head injury.
However, these findings bear confirmation in a larger
cohort of TBI patients, because our study was under-
powered to exclude a small effect in this subgroup.
When viewed in light of previous research in this area
showing harm from hyperoxia in some populations and
not others, this study supports the hypothesis that the
association of higher PaO2 with mortality depends on
the nature of the patient population studied.







Age (Increment of 5 years) 1.05 1.00–1.10 0.04
Injury Severity Score (Increment of 5) 1.24 1.05–1.48 0.01
Number of ABGs Measured 1.11 1.02–1.21 0.01
FiO2 at time of ABG (Increment of 10%) 0.93 0.83–1.05 0.25
Maximum PaO2 (Increment of 1 fold) 0.96 0.71–1.31 0.82
aodds ratio for lower GCS








Age (Increment of 5 years) 1.22 1.09–1.36 <0.001
Injury Severity Score (Increment of 5) 1.28 0.86–1.91 0.23
Number of ABGs Measured 1.15 0.98–1.37 0.10
FiO2 at time of ABG (Increment of 10%) 0.88 0.69–1.12 0.29
Maximum PaO2 (Increment of 1 fold) 1.55 0.79–3.02 0.20
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